38892217|t|Human C15orf39 Inhibits Inflammatory Response via PRMT2 in Human Microglial HMC3 Cell Line.
38892217|a|Microglia-mediated inflammatory response is one key cause of many central nervous system diseases, like Alzheimer's disease. We hypothesized that a novel C15orf39 (MAPK1 substrate) plays a critical role in the microglial inflammatory response. To confirm this hypothesis, we used lipopolysaccharide (LPS)-and interferon-gamma (IFN-gamma)-induced human microglia HMC3 cells as a representative indicator of the microglial in vitro inflammatory response. We found that C15orf39 was down-regulated when interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFalpha) expression increased in LPS/IFN-gamma-stimulated HMC3 cells. Once C15orf39 was overexpressed, IL-6 and TNFalpha expression were reduced in LPS/IFN-gamma-stimulated HMC3 cells. In contrast, C15orf39 knockdown promoted IL-6 and TNFalpha expression in LPS/IFN-gamma-stimulated HMC3 cells. These results suggest that C15orf39 is a suppressive factor in the microglial inflammatory response. Mechanistically, C15orf39 interacts with the cytoplasmic protein arginine methyltransferase 2 (PRMT2). Thus, we termed C15orf39 a PRMT2 interaction protein (PRMT2 IP). Furthermore, the interaction of C15orf39 and PRMT2 suppressed the activation of NF-kappaB signaling via the PRMT2-IkappaBalpha signaling axis, which then led to a reduction in transcription of the inflammatory factors IL6 and TNF-alpha. Under inflammatory conditions, NF-kappaBp65 was found to be activated and to suppress C15orf39 promoter activation, after which it canceled the suppressive effect of the C15orf39-PRMT2-IkappaBalpha signaling axis on IL-6 and TNFalpha transcriptional expression. In conclusion, our findings demonstrate that in a steady condition, the interaction of C15orf39 and PRMT2 stabilizes IkappaBalpha to inhibit IL-6 and TNFalpha expression by suppressing NF-kappaB signaling, which reversely suppresses C15orf39 transcription to enhance IL-6 and TNFalpha expression in the microglial inflammatory condition. Our study provides a clue as to the role of C15orf39 in microglia-mediated inflammation, suggesting the potential therapeutic efficacy of C15orf39 in some central nervous system diseases.
38892217	0	5	Human	Species	9606
38892217	6	14	C15orf39	Gene	56905
38892217	24	36	Inflammatory	Disease	MESH:D007249
38892217	50	55	PRMT2	Gene	3275
38892217	59	64	Human	Species	9606
38892217	76	80	HMC3	CellLine	CVCL:II76
38892217	111	123	inflammatory	Disease	MESH:D007249
38892217	158	189	central nervous system diseases	Disease	MESH:D002493
38892217	196	215	Alzheimer's disease	Disease	MESH:D000544
38892217	246	254	C15orf39	Gene	56905
38892217	256	261	MAPK1	Gene	5594
38892217	313	325	inflammatory	Disease	MESH:D007249
38892217	372	390	lipopolysaccharide	Chemical	MESH:D008070
38892217	392	395	LPS	Chemical	MESH:D008070
38892217	401	417	interferon-gamma	Gene	3458
38892217	419	428	IFN-gamma	Gene	3458
38892217	438	443	human	Species	9606
38892217	454	458	HMC3	CellLine	CVCL:II76
38892217	522	534	inflammatory	Disease	MESH:D007249
38892217	559	567	C15orf39	Gene	56905
38892217	592	605	interleukin-6	Gene	3569
38892217	607	611	IL-6	Gene	3569
38892217	617	644	tumor necrosis factor-alpha	Gene	7124
38892217	646	654	TNFalpha	Gene	7124
38892217	680	683	LPS	Chemical	MESH:D008070
38892217	684	693	IFN-gamma	Gene	3458
38892217	705	709	HMC3	CellLine	CVCL:II76
38892217	722	730	C15orf39	Gene	56905
38892217	750	754	IL-6	Gene	3569
38892217	759	767	TNFalpha	Gene	7124
38892217	795	798	LPS	Chemical	MESH:D008070
38892217	799	808	IFN-gamma	Gene	3458
38892217	820	824	HMC3	CellLine	CVCL:II76
38892217	845	853	C15orf39	Gene	56905
38892217	873	877	IL-6	Gene	3569
38892217	882	890	TNFalpha	Gene	7124
38892217	905	908	LPS	Chemical	MESH:D008070
38892217	909	918	IFN-gamma	Gene	3458
38892217	930	934	HMC3	CellLine	CVCL:II76
38892217	969	977	C15orf39	Gene	56905
38892217	1020	1032	inflammatory	Disease	MESH:D007249
38892217	1060	1068	C15orf39	Gene	56905
38892217	1138	1143	PRMT2	Gene	3275
38892217	1162	1170	C15orf39	Gene	56905
38892217	1173	1178	PRMT2	Gene	3275
38892217	1200	1205	PRMT2	Gene	3275
38892217	1243	1251	C15orf39	Gene	56905
38892217	1256	1261	PRMT2	Gene	3275
38892217	1291	1300	NF-kappaB	Gene	4790
38892217	1319	1324	PRMT2	Gene	3275
38892217	1325	1337	IkappaBalpha	Gene	4792
38892217	1408	1420	inflammatory	Disease	MESH:D007249
38892217	1429	1432	IL6	Gene	3569
38892217	1437	1446	TNF-alpha	Gene	7124
38892217	1454	1466	inflammatory	Disease	MESH:D007249
38892217	1479	1491	NF-kappaBp65	Gene	5970
38892217	1534	1542	C15orf39	Gene	56905
38892217	1618	1626	C15orf39	Gene	56905
38892217	1627	1632	PRMT2	Gene	3275
38892217	1633	1645	IkappaBalpha	Gene	4792
38892217	1664	1668	IL-6	Gene	3569
38892217	1673	1681	TNFalpha	Gene	7124
38892217	1797	1805	C15orf39	Gene	56905
38892217	1810	1815	PRMT2	Gene	3275
38892217	1827	1839	IkappaBalpha	Gene	4792
38892217	1851	1855	IL-6	Gene	3569
38892217	1860	1868	TNFalpha	Gene	7124
38892217	1895	1904	NF-kappaB	Gene	4790
38892217	1943	1951	C15orf39	Gene	56905
38892217	1977	1981	IL-6	Gene	3569
38892217	1986	1994	TNFalpha	Gene	7124
38892217	2024	2036	inflammatory	Disease	MESH:D007249
38892217	2092	2100	C15orf39	Gene	56905
38892217	2123	2135	inflammation	Disease	MESH:D007249
38892217	2186	2194	C15orf39	Gene	56905
38892217	2203	2234	central nervous system diseases	Disease	MESH:D002493
38892217	Positive_Correlation	MESH:D008070	7124
38892217	Positive_Correlation	3458	7124
38892217	Association	MESH:D007249	3275
38892217	Association	MESH:D007249	3569
38892217	Association	3275	56905
38892217	Negative_Correlation	3569	56905
38892217	Association	MESH:D007249	5970
38892217	Negative_Correlation	3275	4790
38892217	Positive_Correlation	MESH:D008070	3569
38892217	Association	MESH:D007249	7124
38892217	Association	5594	56905
38892217	Negative_Correlation	3275	7124
38892217	Association	56905	5970
38892217	Association	3275	4792
38892217	Negative_Correlation	MESH:D007249	56905
38892217	Negative_Correlation	56905	7124
38892217	Negative_Correlation	4790	56905
38892217	Association	MESH:D008070	56905

